Full HTML 03 V2 I5

Synthesis and Initial Cancer Cell Results of Organotin Polyethers Derived From the Anticoagulant Dicumarol


Charles E. Carraher, Jr.,1 Michael R. Roner2Nandalall Sookedo,1  Alisa Moric-Johnson,2  Lindsey Miller,2  James D. Johnson,1


1.  Florida Atlantic University, Department of Chemistry and Biochemistry, Boca Raton, FL 33431 USA
2. University of Texas Arlington, Department of Biology, Arlington, TX 76010 USA

ABSTRACT

Organotin polyethers are synthesized from the interfacial polymerization of dicumarol and diorganotin dihalides in near 100% yields.  The products show infrared bands characteristic of the formation of the Sn-O linkage.  MALDI MS shows ion fragment clusters to two units.  Isotopic abundance comparisons are consistent with the present of tin atoms in the ion fragment clusters.  Proton NMR is consistent with the presence of both reactants in the product and absence of the dicumarol protons.  The products exhibit cell inhibition towards all of the cancer cell lines including two pancreatic cancer and breast cell lines.

Keywords:  organotin polyethers, organotin polymers, MALDI MS, pancreatic cancer, cancer, dicumarol.

INTRODUCTION

The present research is part of an overall effort to synthesize polymers that can be employed in the inhibition of various unwanted pathogens and infectious agents, here cancer.   One rational to our synthesis is to couple metal-containing moieties that are known to exhibit biological activity with Lewis bases that also exhibit biological activity in hopes that the combination will have a synergic affect.  Organotin compounds are well known for their biological activity.  Some of our activity involving organotin polymers has been recently reviewed [1-3].  More organotin compounds are available commercially than any other metal-containing organometallics [4,5].  Further, more organotin compounds have undergone testing as potential anticancer agents than any other single group of compounds [2-5].

Dicumarol or dicoumarol is an anticoagulant that acts as a Vitamin K antagonist similar to warfarin. As such, it prohibits the formation of prothrombin and factors VII, IX, and X in the liver.  It is used in the prevention and treatment of thromboemboic disorders as well as embolisms. In biochemistry, it is also employed as a reductase inhibitor. It binds plasmatic proteins [6]. It is sold under a number of generic names including BHC, bishydroxycoumarin and dicoumarin. It is also available under a number of trade names including Acadyl, Acavyl, Antitrobosin, Baracoumin, Cuma, Cumid, Dicoumal, Dicman, Dicumarine, Dicumol, Dufalone, Kumoran, Melitoxin, Temparin, and Trombosan.  It is among the most widely used drugs as a “blood thinner” and oral anticoagulant interfering with the metabolism of vitamin K.

Dicumarol is produced by conversion of nontoxic coumarin in moldy sweet clover hay, lespepeza hay, and sweet vernal hay.  Eating hay results in blood loss due to spontaneous hemorrhaging [6]. Dicumarol has been shown to be involved in a number of biological activities.  For instance, Abdelmohsen and coworkers have found that it is a potent reversible inhibitor of gap junctional intercellular communication [7].   Mironov and coworkers report that it is an inhibitor of ADP-ribosylation of CtBP3/BARS, fragments golgi non-compact zones, and inhibits intra-golgi transport [8].  Culler and coworkers report its use in the inhibition of NADPH [9].

Thus, there is sufficient evidence that dicumarol is active in a variety of biological activities thus fulfilling our desire that the non-metal containing moiety also offers biological activity. Dicumarol has not been previously incorporated into polymers but has been used extensively in polymeric matrices for control release [for instance 10]. Here we report preliminary results for the polymers synthesized from various organotin dihalides and dicumarol. The synthesis is affected employing the interfacial polymerization between dicumarol and the various diorganotin dihalides as shown below.

Figure 1: Overall reaction between dicumarol and organotin dihalides, here organotin dichlorides where R represents alkyl/aryl substituents on tin and R1 chain extension.

Material and Methods

Synthesis

Diphenyltin dichloride (1135-99-5), dicumarol (66-76-2)), dimethyltin dichloride (753-73-1) and dibutyltin dichloride (683-18-1) were purchased from Aldrich Chemical Co., Milwaukee, WS; diethyltin dichloride (866-55-7) was obtained from Peninsular Chemical Res., Gainesville, FL; dioctyltin dichloride (3542-36-7) and dicyclohexyltin dichloride (3342-69-6) were obtained from Ventron Alfa Inorganics, Beverly, Mass.

Reactions were carried out using the interfacial polycondensation technique.  Briefly, an aqueous solution (30 ml) containing the camphoric acid (0.00300 mol) and sodium hydroxide ( 0.0090 mol) was transferred to a one quart Kimax emulsifying jar fitted on top of a Waring Blender (model 1120; no load speed of about 18,000 rpm; reactions were carried out  at about 25 oC).  Because the diacid form of dicumarol is not a strong nucleophile, base is added converting dicumarol to its salt which is a reasonably strong nucleophile.

Stirring was begun and a hepane solution (30 ml) containing the organotin dihalide (0.00300 mol) was rapidly added (about 3-4 seconds) through a hole in the jar lid using a powder funnel.  The resulting solution was blended for 15 seconds.  The precipitate was recovered using vacuum filtration and washed several times with deionized water and heptane to remove unreacted materials and unwanted by-products.  The solid was washed onto a glass petri dish and allowed to dry at room temperature.

Structural Characterization

Light scattering photometry was carried out with the samples dissolve in DMSO employing a Brice-Phoenix Universal Light Scattering Photometer Model 4000.  Infrared spectra were obtained employing attenuated total reflectance infrared spectroscopy utilizing a JASCO FT/IR-4100 fitted with an ATR Pro 450-s. 1H NMR spectra were obtained employing Varian Inova 400 MHz and Varian 500 MHz spectrometers.   MALDI MS High resolution electron impact positive ion matrix assisted laser desorption ionization time of flight, HR MALDI-TOF, mass spectrometry was carried out employing a Voyager-DE Pro MALDI mass spectrophotomer, Applied Biosystems, Foster City, CA.

The solid polymeric material was ground and then exposed to vortex mixing using copper spheres for 2 min.  A small amount of the resultant fine powder was adsorbed onto the surface of 1μl matrix (alpha-cyano-4-hydroxycinnamic acid), CHA. The standard settings were used with a reflector mode of operation and an accelerating voltage of 25,000 volts; grid voltage 90% and an acquisition mass range of 500 to 2,000.  Fifty to two hundred shots were typically taken for each spectrum.  Results employing alpha-cyano-4-hydroxycinnamic acid are included in the present paper. The solid product and solid matrix were mixed together employing copper spheres giving a fine powder that was employed to obtain the spectra.

Cell Testing

The toxicity of each test compound was evaluated with the human pancreas adenocarcinoma cell line (AsPC-1), human pancreas epithelioid duct carcinoma cell line (PANC-1) or mouse embryo-fibroblast (NIH/3T3) cell line or other cell line. Following a 24 h incubation period, the test compounds were added at concentrations ranging to 60 microgram/mL and allowed to incubate at 37°C with 5% CO2 for 72 h. Following incubation, Cell Titer-Blue reagent (Promega Corporation) was added (20 uL/well) and incubated for 2 h. Fluorescence was determined at 530/590 nm and converted to % cell viability versus control cells.

All cytotoxicity values are calculated against a base-line value for each line that was generated from “mock-treatment” of the normal and tumor cell lines with media supplemented with all diluents used to prepare the chemotherapeutic compounds.  For example, if the compounds were dissolved in DMSO and serial dilutions prepared in Delbecco’s Modified Eagle’s Medium, MEM, to treat the cells, then the mock-treated cells were “treated” with the same serial dilutions of DMSO without added chemotherapeutic compound.  This was done to ensure that any cytotoxicity observed was due to the activity of the compound and not the diluents.  For the studies reported here, the mock-treatment never resulted in a loss of cell viability of more than one percent, demonstrating that the activity observed was not due to cytotoxicity of any of the diluents used, but was due to activity of the tested compounds. Standard dilutions are employed beginning with the most concentrated with essentially total inhibition occurring to the most dilute where little or no inhibition occurs.  The inhibition curve is sigmoid and the EC50 determined at the midpoint of the curve.  Once inhibition begins the concentration difference between the initial inhibition and final total inhibition is steep with the region between initial to final total inhibition essentially linear.

RESULTS AND DISCUSSION

Yield and Chain Length             

Synthesis was carried out employing a classical interfacial polycondensation.  Product yield is given in Table 1.

Table 1:  Product yield from the synthesis of Group VA polymers from reaction with dicumarol

Organotin Moiety Percentage Yield Molecular Weight Chain Length
Me2Sn 97 7.3 x 104 150
Ete2Sn 99 1.9 x 104 37
Bu2Sn 98 4.0 x 104 70
Cy2Sn 98 2.3 x 105 370
Oc2Sn 56 1.6 x 105 200
Ph2Sn 99 72.2 x 104 36

The reaction is rapid (less than 15 seconds stirring time) employing commercially available reactants and the interfacial reaction system that is currently employed in the synthesis of aromatic amides and polycarbonates.  Thus, the process can employed in the production of grams to tons of product.   Product yields are high, all above 90%, with the exception of the dioctyltin product.  It is possible that the extended chain length of the octyl moiety inhibits rapid close contact of the reactants resulting is decreased yield.

It is instructive to remember that the active form of the dicumarol is the form as shown in Figure 2 since strong base, NaOH, is added forming the deprotonation of the aromatic hydroxide groups of the dicumarol.

Figure 2: Active structure of dicumarol for the reaction system

Table 1 also contains the average chain lengths for each of the products. The products are low to medium polymers with chain length ranging from 36 to 370 repeat units.  There appears to be no trend with respect to chain length.  The dioctyltin product shows the lowest yield yet the highest chain length.  The shortest alkyltin chain length, the dimethyltin, shows the next greatest chain length.  The lack of specific trends is not unexpected since the reaction is complex and chain length and yield probably depend on a number of factors including solubility in each phase, rapidity that the reactants enter the reaction zone, and product solubility since the products are collected as precipitates from the reaction system.

Infrared Spectroscopy 

Infrared spectral analysis was carried out for all of the samples over the range of 4000-650 cm-1.  All band locations are given cm-1.  Infrared spectral analysis is consistent with the proposed structure and with other reported analyses [11-24]. The spectra all show bands characteristic of both reactants and new bands for the product assigned to the Sn-O linkage (Table 2).    A new band for the Sn-O-C tin-ether linkage is found about 1050.  For the dimethyltin product this is found at 1055; diethyltin product at 1057; dibutyltin product 1055, dicyclohexyltin product at 1060; dioctyltin product at 1060 and the diphenyltin product at 1053.

The OH stretch at about 3746 is small for dicumarol and absent for the products. For C-H stretching about 3000, dicumarol has bands about 3083 and 3063 corresponding to the aromatic C-H stretch and bands at 2991 and 2902 for aliphatic symmetric CH and 2840, 2796, 2752, and 2727 for asymmetric CH stretching.  Dibutyltin dichloride has bands at 2960, 2927, 2872 and 2858.  The dibutyltin polymer shows bands at 3081, 3066, 2955, 2924, 2871, 2840, 2755 and 2732 showing bands from both the dibutyltin and dicumarol moieties. Diphenyltin dichloride itself shows bands at 3068 and 3051 and the polymer shows bands at 3064, 3042 from the diphenyltin moiety and bands at 2990, 2902, 2845, 2804, 2752, and 2732 derived from the dicumarol moiety.

Bands characteristic of the carbonyl of the internal ester from dicumarol occur at 1644 and for the dibutyltin polymer and diphenyltin polymer both at 1644. Additional band assignments are given in table 2 and are consistent with the presence of units from both the organotin and dicumarol. Thus, infrared spectroscopy is consistent with the presence of units from both reactants and the formation of new bands consistent with the formation of the expected Sn-O linkage.

Table 2:  Selected infrared bands for the monomers and polymers associated with the dibutyltin and diphenyltin polymers. 

Band Assignment Dicumarol Bu2SnCl2 Bu2Sn Polymer Ph2SnCl2 Ph2Sn Polymer
OH St 3746
CH St Aromatic 3083, 3063 3081, 3066 3068, 3051 3064, 3042
CH Sym St Aliph 2991, 2902 2960, 2927 2955, 2924 2990, 2902
CH Asym St Aliph 2840, 2796, 2752,

2727

2872, 2858 2871,

2858,

2840  2755, 2732

2845, 2804, 2752, 2732
C=O St 1644 1644 1644
Ring CC ip St 1598, 1566, 1499, 1437 1599, 1567, 1502, 1427 1599, 1567, 1503, 1428
Sn-Ph St 1480, 1071 1481, 1076
CH3 Sym St 1463 1453
C=C St 1432, 1332 1429, 1329
CH3 Asy Bend 1380 1346
C-OH St 1320
CH2 twist 1345 1346 1347
Ring CC ip St 1277, 1216, 1279, 1219, 1279, 1219
CO st int esters 1163, 1106 1163, 1107 1163, 1108
Sn-O-C 1055 1053
Ring Breathing 996 997
CH3 Rock 878 876
Syn op Bend Ring Hydrogens 729 729
Asy op Bend Ring Hydrogens 691 692

NMR

NMR was run for the dicumarol in d3-chloroform and for the remainder of the compounds in d-6 DMSO.  Results are consistent with those reported in the literature [11-19, 25, 26].All bands are given in ppm.  Dicumarol itself shows a singlet at 11.3 from the acid proton which is absent in the polymers; double at 7.99; triplet at 7.59, several bands between 7.39 to 7.34; and a singlet at 3.84.  Diphenyltin dichloride shows bands at 7.85 (ortho), and 7.41 and 7.31.  The polymer has bands from the diphenyltin moiety at 7.85, 7.38 and 7.30 and from the dicumarol moiety at 7.98, 7.61, 7.36-7.30, and 7.37 consistent with the presence of moieties of both reactants.  Dimethyltin dichloride shows bands at 1.3.  The product shows bands at 1.32 from the dimethyltin moiety and 7.98, 7.58, 7.35-3.34 and 3.82.  Diethyltin shows bands at 1.67 (methylene) and 1.25 (methyl).  The polymer shows bands at 1.65 and 2.14 from the diethyltin moiety and 7.81, 7.68, 7.40 to 7.29, and 3.74.  Thus, proton NMR shows bands consistent with the presence of both reactant moieties and absence of the protons from dicumarol.  Finally, because of the poor solubility of the polymers, other data is not confidently reported.

MALDI MS

MALDI MS was developed to allow mass spectrometry to be run on polymeric samples [27-30]     For about a dozen years we and others have been employing MALDI MS for the identification of a number of non-volatile metal and non-metal containing polymers [1,11-19]. The technique employed by us is not straight forward MALDI MS but it is applicable to soluble and insoluble products so has wide potential for application.  Since this new technique focuses on the fragments that are created in the MALDI MS process, the approach is sometimes referred to as Fragmentation Matrix-Assisted Laser Desorption/ Ionization mass spectrometry or simply F MALDI MS because it is the fragments that are emphasized in the study.  The technique should be applicable to any solid when the proper operating conditions are employed. There are some complications employing this technique to organotin because of rearrangements and the particular sensitivity of organotin moieties to laser radiation. It has been recently reviewed [31-33].

Figure 3 contains the MALDI MS for the product of dicumarol and dibutyltin dichloride. Table 3 contains the major ion fragment clusters for the product from dibutyltin dichloride and dicumarol.  Several abbreviations as follows: U = one unit; Bu = butyl moiety, DC is the dicumarol unit minus two hydrogen atoms and Na for sodium.  Sodium is a common contaminant. As in other cases, some of the ion fragment clusters are derived from reaction of the organotin moiety with the matrix [31-33].  One of these is noted in Table 3. The structure of this ion fragment cluster is given in Figure 4 and its isotopic abundance is consistent with the presence of a single tin atom. These will be omitted in other tables since they do not assist in the identity of the repeat unit of the polymers.  The ion fragments typically show no fragmentation of the dicumarol in spite of the presence of the internal ester that could be evolved as CO2 and the methylene unit connecting the two major ring systems in dicumarol.  This is consistent with the mild nature of MALDI MS.

Figure 3:  MALDI MS of the product of dibutyltin and dicumarol over the approximate mass range of 500 to 700 Da.

Table 3:  Most abundant ion fragment clusters derived from the product of dibutyltin dichloride and dicumarol (where M = matrix molecule)

Ion Fragment Cluster, Da (Tenative) Assignment Ion Fragment Cluster, Da (Tentative) Assigmnent
522 U-O 670 U+Sn-O
569 U 741 U+SnBu
591 U,Na 769 U+SnBu
607 U+O,Na 816 U+ Bu2SnO
633 2M+ Bu2Sn,Na 839 U+ Bu2SnO,Na
902 U+DC

The presence of tin within the ion clusters is indicated by the “tell-tale” fingerprint caused by the isotopic abundance of these tin isotopes. This is evident in the MALDI MS patterns shown in Figure 3 for the ion fragment clusters given at about 564, 591, 607, 634, and 670 Da.

The ion clusters contain intact segments along with some units minus the tin associated butyl groups.  The loss of groups associated with tin is common and emphasizes the instability of the tin moiety probably because of its reported instability to energy in the range of the employed laser light source [31-33].

Tin has eleven isotopes; seven have natural abundances greater than 10%.  Thus isotopic abundance matches can be done.  Three matches are given in Table 4 for ion fragment clusters containing a single tin atom.  Table 5 contains two such matches for ion fragment clusters containing two tin atoms.  The agreement with the expected, “Known-left two columns”, is reasonable consistent with the presence of two tin atoms in the cluster.  As noted before, because of the instability of the organotin bonding to the laser light, it is not uncommon for loss of the organic moiety, here the butyl group. This loss generally occurs at the site of bond breakage [11-19].  The dicumarol rings remain intact consistent with the mild conditions present for MALDI MS.

Figure 4:  Proposed structure of the matrix-associated ion fragment cluster found about 634 where R is a butyl group.

Table 4:  Isotopic abundance matches for three ion fragment clusters containing a single tin atom for the dibutyltin dichloride product. 

Known for Sn U U,Na          U+O,Na  
116 45 565 48 587 45 603 47
117 24 566 31 588 31 604 23
118 75 567 76 589 74 605 76
119 26 568 32 590 38 606 28
120 100 569 100 591 100 607 100
122 14 571 15 593 15 609 13
124 17 573 18 595 19 611 16

Table 5: Isotopic abundance matches for two tin-containing ion fragment clusters containing two tin atoms for the dibutyltin product.

Known for Sn 2U+Bu2SnO 2U+Bu2SnO,Na
232 12 810 14 833 14
233 13 811 15 834 16
234 43 812 44 835 43
235 35 813 35 836 33
236 94 814 93 837 90
237 51 815 53 838 51
238 100 816 100 839 100
239 35 817 36 840 35
240 81 818 82 841 87
242 32 820 30 843 32
244 22 822 24 845 24

In each case, ion fragment clusters given in Tables 4 and 5 are consistent with the presence of tin in the associated ion fragment clusters. The most abundant ion fragment clusters for the product of diphenyltin dichloride and dicumarol are given in Table 6.

Table 6:  Most abundant ion fragment clusters derived from the product of diphenyltin dichloride and dicumarol.

Ion Fragment Cluster, Da (Tenative) Assignment Ion Fragment Cluster, Da (Tentative) Assigmnent
550 U+O-Ph 882 U+Ph2Sn
608 U 942 U+DC
630 U+Na 1055 2U-2Ph,O
646 U+O,Na 1071 2U-2Ph
749 U+Sn,Na 1087 2U+O-2Ph
769 U+Sn,Na,O 1336 2U+Sn

Table 7 contains the isotopic abundance matches for three ion fragment clusters containg a single tin atom.  Table 8 contains two matches for ion fragment clusters containing two tin atoms. The matches are reasonable consistent with the presence of tin atom(s) in these ion fragment clusters. 

Table 7:  Isotopic abundance matches for three ion fragment clusters containing a single tin atom for the diphenyltin product. 

Known for Sn U U,Na          U+O,Na  
116 45 604 45 626 48 642 47
117 24 605 23 627 24 643 24
118 75 606 75 628 78 644 75
119 26 607 28 629 29 645 29
120 100 608 100 630 100 646 100
122 14 610 15 632 14 648 14
124 17 612 18 634 20 650 18

Table 8:   Isotopic abundance matches for two tin-containing ion fragment clusters containing two tin atoms for diphenyltin products. 

Known for Sn 2U-2Ph,O 2U+-2Ph
232 12 1049 10 1065 14
233 13 1050 13 1066 15
234 43 1051 44 1067 42
235 35 1052 32 1068 30
236 94 1053 92 1069 90
237 51 1054 53 1070 55
238 100 1055 100 1071 100
239 35 1056 34 1072 36
240 81 1057 76 1073 78
242 32 1059 30 1075 31
244 22 1061 21 1077 24

The other products gave similar results.  Thus, MALDI MS is consistent with the proposed repeat unit structure.  Further, the results are consistent with chain scission occurring at the hetroatom tin and oxygen atoms as shown in Figure 5 consistent with other studies [11-16] producing the ion fragment clusters cited in Tables 3 and 6.

Figure 5:  Sites of preferred polymer backbone bond scission.

Tumor analysis

The battery of test cancer cell lines used in this study is given in Table 8. They represent a broad range of solid cancer cell lines.

Table 8: Cell lines employed in the current study

Strain # NCI Desig. Species Tumor Origin Histological Type
3465 PC-3 Human Prostate Carcinoma
7233 MDA MB-231 Human Pleural effusion breast Adenocarcinoma
1507 HT-29 Human Recto-sigmoid colon Adenocarcinoma
7259 MCF-7 Human Pleural effusion-breast Adenocarcinoma
ATCC CCL-75 WI-38 Human Normal embryonic lung Fibroblast
CRL-1658 NIH/3T3 Mouse Embryo-continuous cell line of highly contact-inhibited cells Fibroblast
AsPC-1 Human Pancreatic cells Adenocarcinoma
PANC-1 Human Epithelioid pancreatic cells Carcinoma

In other studies we found that the polymer drugs are cytotoxic and cell death is by necrosis [1-3]. We have recently found that the anticancer activity is brought about by the intact polymer and not through polymer degradation [1-3, 33].  This is consistent with studies that show the polymers are stable in DMSO with half-chain lives, the time for the polymer chain length to halve, generally in excess of 30 weeks [1-3]. While it is well known that most organometallic compounds associate with polar solvents such as DMSO and that the biological results may be influenced by the presence of the DMSO [1,3,34-38], for polymers similar to those described in the present study, this influence is found to be small, generally less than 20% [1-3,35].

While different measures have been employed in the evaluation of cell line results, the most widely employed involve the concentration, dose, needed to reduce the growth of the particular cell line.  Here the term effective concentration, EC, is used. The concentration of a drug, antibody, or toxicant that induces a response halfway between the baseline and maximum after a specified exposure time is referred to as the 50% response concentration and given the symbol EC50.

Table 9 contains the EC50 values for the monomers and polymers and among the most widely used anticancer drugs, cisplatin.  The monomer dicumarol offers no inhibition of any cell line to the highest concentration tested.  Thus, inhibition of the cancer cells comes from the combination of the organotin with the dicumarol or presence of the organotin moiety.

Much of our recent effort has been on discovering compounds that inhibit pancreatic cancer because pancreatic cancer has no generally accepted “cure” [1-3, 20-22]. Two widely employed human pancreatic cell lines are included in the present study. These are the AsPC-1 cell line which is an adenocarcinoma pancreatic cell line representing the most often observed pancreatic cancer cell line found in humans (about 80%) and the PANC-1 cancer cell line which is an epithelioid carcinoma pancreatic cell line representing the second most frequently observed pancreatic cancer cell line found in humans (about 10%).  All of the organotin polyethers inhibit both pancreatic cancer cell lines.  The inhibition of the pancreatic cancer cell lines is similar for both the ASPC-1 and PANC-1 cells indicating that inhibition by the polymers may be general for the other pancreatic cancers.

The two breast cancer cell lines represent a matched pair.  The MCF-7 (strain line 7259) cells are estrogen receptor (ER) positive while the MDA-MB-231 (strain number 7233) cells are estrogen-independent, estrogen receptor negative.  In some studies involving organotin polymers there was a marked difference between the ability to inhibit the two cell lines dependent on polymer structure [1-3, 20-22]. Where there is a marked difference it is found that the Lewis base is attached to the organotin moiety through a O-Phenylene grouping which is similar to that present in molecules used to treat breast cancer such as diethylstilbestrol. In the current study there is not a great difference in the ability to inhibit the two cell lines by the polymers with the polymers inhibiting both breast cancer cell lines with about the same EC50 though the connection between the tin and Lewis base does contain similar linkage.  The polymers also exhibit good inhibition of the prostrate (PC-3) and colon (HT-29) cancer cell lines.

Table 8:  EC50 Concentrations (micrograms/mL) for the tested compounds, Values Given in ( ) are Standard Deviations for Each Set of Measurements.

Sample 3T3 WI-38 PANC-1 AsPC-1
Me2SnCl2 0.43 (.1) 0.22(.1) 0.80(.1) 0.71(.1)
Me2Sn/DC 12(1) 10(1) 12(1) 12(1)
Et2SnCl2 0.46(.1) 0.20(.1) 0.48(.1) 0.90(.1)
Et2Sn/DC 23(2) 20(2) 22(2) 20(2)
Bu2SnCl2 0.20 (.05) 0.20(.05) >15 >15
Bu2Sn/DC 10(1) 10(1) 11(1) 11(1)
Cy2Sn/DC 10.(1.) 11.(1.) 11.(1.) 11.(1.)
Oc2SnCl2 0.56(.1) 0.30(.1) 0.85(.1) 0.85(.1)
Oc2Sn/DC 11(1) 11(1) 12(1) 11(1)
Ph2SnCl2 0.66(.1) 0.25(.1) 0.71(.1) 0.83(.1)
Ph2Sn/DC 10(1) 11(1) 11(1) 10(1)
 Dicumarol >60 >60 >60 >60
Cisplatin 15(10) 1.2(0.1) 1.4(.1) 0.340(.1)

 

Sample PC-3 MDA-MB-231 HT-29 MCF-7
Me2SnCl2 0.51(.1) 0.44(.1) 0.56(.1) 0.66(.1)
Me2Sn/DC 10(1) 11(1) 14(1) 14(1)
Et2SnCl2 0.61(.1) 0.64(.1) 0.71(.1) 0.77(.1)
Et2Sn/DC 21(2) 22(2) 22(2) 22(2)
Bu2SnCl2 1.4(1.1) 1.4(1.3) 1.2(.1) 0.7(.06)
Bu2Sn/DC 10(1) 11(1) 12(1) 11(1)
Cy2Sn/DC 11.(1.) 11.(1.) 11.(1.) 11.(1.)
Oc2SnCl2 0.55(.1) 0.65(.1) 0.65(.1) 0.70(.1)
Oc2Sn/DC 15(1) 12(1) 13(1) 11(1)
Ph2SnCl2 0.82(.1) 0.76(.1) 0.56(.1) 0.68(.1)
Ph2Sn/DC 11(1) 13(1) 12(1) 11(1)
Dicumarol >60 >60 >60 >60
Cisplatin 1.00(0.10) 3.00(0.28) 2.00(0.21) 1.00(0.1)

CONCLUSIONS

Organotin polyethers are synthesized from the interfacial polymerization of dicumarol and diorganotin dihalides in near 100% yields. All of the reactants are commercially available and the synthetic system is employed industrially to product aramid fibers and polycarbonates  [39] thus there should be ready synthesis from milligram to kilogram quantities of the polyethers.  The products show infrared bands characteristic of the formation of the Sn-O linkage.  MALDI MS shows ion fragment clusters to two units.  Isotopic abundance comparisons are consistent with the present of tin atoms in the ion fragment clusters.  Proton NMR is consistent with the presence of both reactants in the product and absence of the dicumarol protons.  The products exhibit cell inhibition towards all of the cancer cell lines including two human pancreatic cancer cell lines and two human breast cell lines.

REFERENCES

  • Carraher C, Roner  MR:  Organotin polymers as  anticancer  and antiviral agents. Organomet. Chem.  2014; 751:67-82.
  • Carraher C: Organotin polymers, In Group IVA Polymers (A. Abd-El-Aziz; C. Carraher; Pittman; M. Zeldin, Eds.). Wiley, Hobokin,
  • Carraher C, Siegman-Louda D: Ogranotin Macromolecules as Anticancer Drugs, in Biomedical Applications (A. Abd-El-Aziz; C. Carraher; Pittman; M. Zeldin, Eds.). Wiley, Hoboken, NJ, 2004.
  • Hoch H: Organotin compounds in the environment. Applied Geochem. 2001; 16:719-743.
  • Davies AG: Organotin Chemistry. Wiley-VCH, Weinheim, German, 2004.
  • Kresge N, Simoni RD, Hill RL: Otto Fritz Meyerhof and the elucidation of the glycolytic pathway. Biol. Chem. 2005, 280:5-10.
  • Abdelmohsen K, Stuhlmann D, Daubrawa F, Klotz L: Dicumarol is a potent reversible inhibitor of gap junctional intercellular communication. Biochem. Biophys. 2004; 434:241-247.
  • Mironov A, Colanzi C, Polishehuk R, Beznoussenko G, Mironov A, Fusella A, Di Tullio G, Silletta M, Corda D, De Matteis M, Luini A: Dicumarol, an inhibitor of ADP-ribosylation of CtBP3/BARS, fragments golgi non-compact tubular zones and inhibits intra-golgi transport. J. Cell. Biol. 2004; 83:263-279.
  • Cullen J, Hinkhouse M, Grady M, Gaut A, Liu J, Zhang Y, Weydert C, Domann F, Oberley L: Dicumarol inhibition of NADPH:quinine oxidoreductase induces growth inhibiton of pancreatic cancer via a superoxide-mediated mechanism. Cancer Res. 2003; 63:5513-5520.
  • Thanos C, Liu Z, Reineke J, Edwards E, Mathiowitz E: Improving relative bioavilability of dicumarol by reducing particle size and adding the adhesive poly(fumaric-co-sebacic) anhydride. Pharm Res. 2003; 20:1093-2000.
  • Carraher C, Roner MR, Shahi K, Moric-Johnson A, Miller L, Barot G, Battin A, Trang N, Alhuniti M: Control of prostate Cancer Using Organotim Polymers. Inorg. Organometal. Polym. 2015; 25:386-399.
  • Carraher C, Roner MR, Ayoub M, Crichton R, Moric-Johnson A, Miller L, Black K: Synthesis of poly(ether esters) from reaction of alpha-cyano-4-hydroxycinnamic acid and group IVB metallocenes. Macromol. Sci. Part A. 2016; 53:328-334.
  • Carraher C, Roner MR, Lambert R, Arroyo L, Miller L: Synthesis of Organotin Polyamine Ethers Containing Thiamine (Vitamin B1) and Preliminary Ability to Inhibit Select Cancer Cell Lines. Inorg. Organomet. Polym. 2015; 25:1414-1424.
  • Carraher C, Truong NTC, Roner MR, Moric-Johnson A, Sookdeo N, Trang N: Synthesis of Organotin Poly(ether Esters) From Reaction With Glycyrrhetinic Acid and Their Preliminary Activity Against Various Cancer Cell Lines. Chim. Acta.  2014; 423:83-92.
  • Carraher C, Morrison A, Roner MR, Moric A, Trang N: Synthesis and Characterization of Organotin Polyesters Derived from 3,5-Pyridinedicarboxylic J. Inorg. Organomet. Polym. 2014; 24:182-189.
  • Carraher C, Roner MR, Carraher CL, Crichton R, Black K: Use of Mass Spectrometry in the Characterization of Polymers Emphasizing Metal-Containing Condensation Polymers. Macromol. Sci. Part A.. 2015; 52:867-886.
  • Carraher C, Roner MR, Shahi K, Moric-Johnson A, Miller L, Barot G, Battin A, Trang N, Sookdeo N, Islam Z: Control of Breast Cancer Using Organotin Polymers. J. Poly. Mater2015;  64:800-814.
  • Carraher C, Truong N, Roner MR, Moric A, Trang N: Synthesis, Structural Characterization and Ability to Inhibit the Growth of Pancreatic Cancer by Organotin Polymers Containing Chelidonic Acid. Chin. Adv. Mat. Soc. 2013; 1:65-73.
  • Carraher C, Roner MR, Shahi K, Battin A, Barot G, Arnold T: Synthesis Organotin Polymers As Chemotherapeutic Agents: Breast and Pancreatic Cancers.   Polym. Mater. 2014; 31:1-14.
  • Carraher C, Roner MR, Shahi K, Barot G: Structural Consideration in Designing Organotin Polyethers to Arrest the Growth of Breast Cancer Cells In Vitro. Materials 2011; 4:801-815.
  • Carraher C, Roner  MR: Organotin polyethers as potential biomaterials.   Materials 2009; 2:1558-1598.
  • Carraher C, Roner MR, Shahi K, Barot K, BattinA: Preliminary results for the inhibition of pancreatic cancer cells by organotin polymers. Inorg. Ogranomet. Polym2009; 19:410-414
  • Barot G, Roner MR, Naoshima Y, Nago K, Shahi K, Carraher C: Synthesis, Structural Characterization, and Preliminary Biological Characterization of Organotin Polyethers Derived from Hydroquinone and Substituted Hydroquinones.   Inorg. Organometal. Polym. 2009; 19:12-27.
  • Hamdi N, Puerta MC, Valerga P: Synthesis, structure, antimicrobial and antioxidant investigations of dicoumarol and related compounds. J. Medicinal Chem. 2008; 43:2541-2548.
  • Porter W, Trager W: 4-Hydroxycumarin/2-hydroxychromone tautomerism: infrared spectra of 3-substituted-2-13C-4-hydroxycoumarins. J. Heterocyclic Chem. 1982; 19:475-480.
  • Ghosh K, Kar D, Frohlich R, Chattopadhyay A, Samadder A, Khuda-Bukhsh A: O-tert-Butyldiphenylsilyl coumarin and dicoumarol: a case toward selective sensing of Fions in organic and aqueous environments.   2013; 138:3038-3045.
  • Barber M, Bordoli RS, Sedwick RD, Tyler AN: Fast atom bombardment of solids as an ion source in mass spectroscopy. 1981; 293:270-275.
  • Liu LK, Busch KL, Cooks RG: Matrix-assisted secondary ion mass spectra of biological compounds. Chem. 1981; 53:109-113.
  • Tanaka K, Waki H, Ido Y, Akita S, Yoshida Y, Yoshida T, Matsuo T: Protein and Polymer Analyses up to m/z 100 000 by Laser Ionization Time-of flight Mass Spectrometry, Rapid Communications in Mass Spectrometry. 1988; 2(20):151–153.
  • Karas, M, Bachmann D, Hillenkamp F: Influence of the Wavelength in High-Irradiance Ultraviolet Laser Desorption Mass Spectrometry of Organic Molecules. Analytical Chemistry. 1985; 57(14):2935–2939.
  • Carraher C, Barot G, Battin A: Reactions between the matrix and ion fragments created  from the  MALDI  MS for  organotin-containing polymers. J. Polym. Mater. 2009;  26:17-31.
  • Carraher C, Sabir T, Carraher CL: Fragmentation matrix assisted laser desorption/ionization mass spectrometry-basics. Polym. Mater. 2006; 23:143-151.
  • Carraher C, Sabir T, Carraher CL: Fundamentals of fragmentation matrix assisted laser desorption/ionization mass spectrometry in Inorganic Organometallic Macromolecules (A. Abd-El-Aziz, C. Carraher, C. Pittman, M. Zeldin, Eds.). Springer, NY, 2008.
  • Carraher C, Barot G, Vetter S, Nayak G, Roner MR: Degradation of the Organotin Polyether Derived From Dibutyltin Dichloride and Hydroxyl-Capped Poly(ethylene Glycol) in Trypsin and Evaluation of Trypsin Activity Employing Light Scattering Photometry and Gel Electrophoresis. Chin, Adv. Mat. Soc. 2013; 1:1-6.
  • Carraher C, Barot G, Shahi K, Roner MR: Influence of DMSO on the Inhibition of Various cancer Cells by Water-Soluble Organotin Poly(ethers). Chin. Adv. Mat. Soc. 2013; 1:294-304.
  • Ohtaki H: Structural studies on salvation and complexation of metal ions in nonaqueous solutions. Pure Appl. Chem. 1987; 59:1143-1150.
  • Gjevig Jenson K, Onfelt A, Wallin M, Lidumas V, Andersen O: Effects of organotin compounds on mitosis, spindel structure, toxicity, and in vitro microtubule assemble. Mutagenessis. 1991; 6:409-416.
  • Corriu R, Dabosi G, Martineau M: The nature of the interactioni of nucleophiles such as HMPT, DMSO, DMF and Ph3PO with triorganohalo-silanes, -germanes, and -stannanes and organophosphorus compounds. Mechanism of nucleophile induced racmization and substitution at metal.   Organomet. Chem. 1980; 186:25-37.
  • Carraher C: Introduction to Polymer Chemistry, Taylor and Francis/CRC Press, NY, 2017.